These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7323362

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives.
    Jones MW, Silverberg SG.
    Obstet Gynecol; 1989 Jun; 73(6):984-9. PubMed ID: 2726119
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Benign liver tumors and oral contraceptives.
    Kolb A.
    Acta Chir Scand; 1982 Jun; 148(1):89-91. PubMed ID: 7136416
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Metrorrhagia caused by estrogen-progestin combinations].
    Erny R, Erny N.
    Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
    [Abstract] [Full Text] [Related]

  • 32. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Honoré LH, Koch M, Brown LB.
    Gynecol Obstet Invest; 1991 Feb; 32(2):98-101. PubMed ID: 1748331
    [Abstract] [Full Text] [Related]

  • 33. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N, Taneepanichskul S.
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [Abstract] [Full Text] [Related]

  • 34. [Oral contraception and cancer risk].
    Genton CY.
    Schweiz Med Wochenschr; 1981 Nov 14; 111(46):1742-8. PubMed ID: 6274005
    [Abstract] [Full Text] [Related]

  • 35. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 14; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Radical radiation therapy for adenocarcinoma of the uterine cervix.
    Toita T, Takizawa Y, Nakano M, Sueyama H, Kushi A, Kakihana Y, Ogawa K, Hara R, Higashi M, Sakumoto K.
    Strahlenther Onkol; 1994 May 14; 170(5):277-80. PubMed ID: 8197550
    [Abstract] [Full Text] [Related]

  • 38. Non-contraceptive benefits of oral contraceptives.
    Prog Hum Reprod Res; 1996 May 14; (39):6-7. PubMed ID: 12292200
    [Abstract] [Full Text] [Related]

  • 39. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun 14; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 40. [Combined contraceptives and cardiovascular risk].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1987 Dec 14; 15(12 Suppl):1-8. PubMed ID: 12315199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.